References
- Moon JJ, Ahn GS, Kim SH, Park JH, Kim DH, Choi DY et al. ShangHanLunJeongHae. 4th. Seoul:HanEuiMunHwaSa. 2019:354-356.
- Liu Duzhou. Proofreading ShangHanLun Dictionary. Seoul:EuiSeongDang. 1991:466.
- Yang Baifu Li Peisheng, Practical formula integration. Chinese People's Health Publishing House. 1996:63.
- Hwang Doyeon. Bangyakhappyeon with Pattern & Pulse. Seoul:NamSanDang. 1977:208.
- Choi Dalyoung. Interpretation & Lecture of ShangHanLun. Seoul:DaeSungMunHwaSa. 1995:282-284.
- Lu Zhijie. Ancient and Modern Application of Zhongjing's Medicinal Formula. 2nd. China:China Pharmaceutical Science and Technology Press. 2000:743.
- Shimada Y, Fujimoto M, Nogami T, Watari H. Adverse Events Associated with Ethical Kampo Formulations: Analysis of the Domestic Adverse-Event Data Reports of the Ministry of Health, Labor, and Welfare in Japan. Evidence-Based Complementary and Alternative Medicine. 2019:2019:1643804. https://doi.org/10.1155/2019/1643804
- Zhang Huihui, Yang Weipeng. Research on Anti-inflammatory Effect and Mechanism of Huangqin Decoction. China Academy of Chinese Medical Sciences. 2014.
- Kim SJ, Lee JB, Choi HM, Lee HY, Kim MJ, Lee MH, et al. Evaluation on Pharmacological Effects and Component Analysis of Hwanggeumjakyak-tang Formulation for Tablet. Korean Journal of Pharmacognosy. 2018:49(4):362-371.
- Heo Joon, DongEuiBoGam with Checkpoint & Index. Seoul:BubInMunHwaSa. 2005:368, 371, 526, 717-718, 1170.
- Changlin Z, Ying Z, Shuhua Z, Zeng J, Chi H. Research on the Protective Effect of MiR-185-3p Mediated by Huangqin-Tang Decoction (HQT) on the Epithelial Barrier Function of Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine. 2021:2021:4775606.
- Korean Pharmacopoeia and Herbal Medicine (Crude Medicine) Specifications. Ministry of Food and Drug Safety.
- Peng Huairen. Dictionary of Chinese Medicine Prescription. China:People's Health Publishing Co. 1986:120.
- Shin CH. Catechetical Herbal Formula Study. Seoul:SeongBoSa. 1992:112-113.
- Peng Huairen. Dictionary of Chinese Medicine Prescription. China:People's Health Publishing Co. 1986:120.
- Wang C, Tang X, Zhang L. Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine. 2017:2017:7016468. https://doi.org/10.1155/2017/7016468
- Zhang BG, Liang XX, Liu QF. Modern pharmacodynamics research and clinic application of huangqintang. Zhongguo Zhong Yao Za Zhi. 2008:33(22):2587-2590.
- Ham IH, Maeng WM, Yang GS, Kim DH, Cho JH, et al. Study on the Variation of Components from Scutellariae Radix by Processing and Storage Condition. The Korea Journal of herbology. 2007:22(2):189-199.
- Herbal medicine explanation and medication guidance, Korean Pharmaceutical Association, 2006.
- Japanese pharmacopoeia. Japanese Pharmacopoeia 17th Edition.
- Kimata Y, Ogawa K, Okamoto H, Chino A, Namiki T. Efficacy of Japanese traditional(Kampo) medicine for treating chemotherapy-induced peripheral neuropathy: A retrospective case series study. World J Clin Cases. 2016:4(10)310-317. https://doi.org/10.12998/wjcc.v4.i10.310
- Chen P, Zhou X, Zhang L, et al. Anti-inflammatory effects of Huangqin tang extract in mice on ulcerative colitis. J Ethnopharmacol. 2015;162:207-214. https://doi.org/10.1016/j.jep.2014.12.039
- Yan MZ, Zuo F, Song HY, Ye WH, Zhou ZM. Comparative study on antibacterial effects of huangqin-tang and its metabolites produced by intestinal flora. Zhongguo Zhong Yao Za Zhi. 2003;28(3):243-246.
- Zou Y, Li WY, Wan Z, Li WY, Zhao B, Lu YJ, et al. Huangqin-Tang Ameliorates TNBS-Induced Colitis by Regulating Effector and Regulatory CD4(+) T Cells. Biomed Res Int. 2015;2015:102021. https://doi.org/10.1155/2015/102021
- Hsu HY, Hsu CS: Commonly Used Chinese Herb Formulas - With Illustrations. Los Angeles: Oriental Healing Art Institute. 1980.
- Zou Y, Lin J, Li W, Wu Z, He Z, Huang G, et al. Huangqin-tang ameliorates dextran sodium sulphate-induced colitis by regulating intestinal epithelial cell homeostasis, inflammation and immune response. Sci Rep. 2016;6:39299. https://doi.org/10.1038/srep39299
- Liu Q, Zuo R, Wang K, Nong FF, Fu YJ, Huang SW, et al. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway. Acta Pharmacol Sin. 2020;41(6): 771-781. https://doi.org/10.1038/s41401-019-0335-4
- Wang YW, Zhang HH, Wang YL, Guo S, Li T, Chen L, et al. Effect of huangqin tang on the regulatory NF-κB p65 signal pathway in rats with ulcerative colitis. Yao Xue Xue Bao. 2015;50(1): 21-27.
- Wang DF, Wang YL, Wang YW, Guo S, Zhuang S, Xu H, et al. Effect of Huangqin Tang on the function of regulatory TLR4/MyD88 signal pathway in rats with ulcerative colitis. Yao Xue Xue Bao. 2016;51(10):1558-1563.
- Wang D, Shi K, Wang Y, Zou D, Guo S, Li T, et al. Effect of Huangqin Tang on Colonic Gene Expression in Rats with Ulcerative Colitis. Int J Genomics. 2020;2020:4238757.
- Zheng XB, Liu HB, Feng YL, Dai SX. Huangqin decoction lowers the number of mast cells in ulcerative colitis in rats with dampness and heat syndrome. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(2):252-255.
- Chen G, Yang Y, Hu C, Cheng X, Xu Y, Cai X, et al. Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice. Oncotarget. 2016;7(38):61643-61655. https://doi.org/10.18632/oncotarget.11426
- Chen D, Zhao J, Cong W. Chinese Herbal Medicines Facilitate the Control of Chemotherapy-Induced Side Effects in Colorectal Cancer: Progress and Perspective. Front Pharmacol. 2018;9:1442. https://doi.org/10.3389/fphar.2018.01442